Kolexia
Viard Jean-Paul Médecine interne
Viard Jean-Paul
Médecine interne
Hôpital Hôtel-Dieu Paris
Paris, France
217 Activités
9.4 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Syndrome d'immunodéficience acquise Carence en vitamine D Inflammation Hépatite Maladies transmissibles Ostéoporose Co-infection COVID-19

Collaborateurs

Voir plus
Rouzioux Christine
Rouzioux Christine
Hôpital Necker Enfants Malades, Paris, France
Avettand Fenoel Veronique
Avettand Fenoel Veronique
Centre Hospitalier Régional D'Orléans Hôpital de La Source, Orléans, France
Salmon-Ceron Dominique
Salmon-Ceron Dominique
Cds Medical Alfred Fournier, Paris, France
Slama Laurence
Slama Laurence
Hôpital Hôtel-Dieu Paris, Paris, France

Industries

Voir plus
The Research Partnership
3 collaboration(s)
Dernière en 2020
MSD
2 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Incident Proteinuria differs by HIV Serostatus among Men with Pre-diabetes: The Multicenter AIDS Cohort Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   09 février 2024
High proportion of post-migration HIV acquisition in immigrant men who have sex with men receiving HIV care in France, and association with social disadvantage and sexual behaviours: Results of the ANRS-MIE GANYMEDE study
HIV medicine Congress 2023   01 décembre 2023
Temporal trends and impact of COVID-19 on the HIV cascade of care across Europe between 2016-2021
HIV medicine Congress 2023   01 décembre 2023
RHIVIERA-02: A Randomised Phase II Placebo-controlled Trial of Antiretroviral Therapy (ART) Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs) vs ART Plus Placebo During Primary HIV-1 Infection to Study the Impact on Post-treatment HIV Control.
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   10 novembre 2023
Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 Genotype: ANRS 175 RHIVIERA-01: Assessment of HIV Remission Upon Combination Antiretroviral Therapy (cART) Interruption in Early Treated Individuals From ANRS CO6 PRIMO Cohort Carrying the Major Histocompatibility Complex (MHC) B35/53Bw4TTC2 Genotype
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   28 septembre 2023
Decrease in CD4 T-Cell Count and Risk of Severe Morbid Conditions in People With Human Immunodeficiency Virus Infection With Controlled Viral Load After Initiating Combination Antiretroviral Therapy Between 2006 and 2018.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   19 avril 2023
Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users.
BMC infectious diseases   17 février 2023
Quantification of Antisense HIV RNA in Patients: Quantification of Antisense VIH-1 Transcripts and Comparison in Different Groups of Patients
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   21 décembre 2022
Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA study.
HIV medicine   08 août 2022
HIV infection : 10 key messages.
La Revue du praticien   16 février 2022